Browsing by Author Pernas, Sònia
Showing results 1 to 20 of 25
next >
| Issue Date | Title | Author(s) |
|---|---|---|
| 2-Nov-2018 | A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study | Martin Castillo, Begoña; Pernas, Sònia; Dorca i Sargatal, Jordi; Álvarez, Isabel; Martínez, Susana; Pérez García, José Manuel; Batista López, Norberto; Rodríguez Sánchez, César A.; Amillano, Kepa; Domínguez, Severina; Luque, Maria; Stradella, Agostina; Morilla, Idoia; Viñas, Gemma; Cortés, Javier; Cuyàs, Elisabet; Verdura, Sara; Fernández-Ochoa, Álvaro; Fernández Arroyo, Salvador; Segura-Carretero, Antonio; Joven, Jorge; Pérez, Elsa; Bosch, Maria Neus; García, Margarita; López Bonet, Eugeni; Saidani, Samiha; Buxó, Maria; Menendez, Javier A. |
| 9-Aug-2023 | Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinelnodes after neoadjuvant therapy (ADARNAT trial) | García-Tejedor, Amparo; Ortega-Exposito, Carlos; Salinas, Sira; Luzardo González, Ana; Falo, Catalina; Martinez-Pérez, Evelyn; Pérez-Montero, Héctor; Soler-Monsó, M. Teresa; Bajén Lázaro, Ma. Teresa; Benítez, Ana; Ortega, Raul; Petit, Anna; Gumà Martínez, Anna; Campos, Miriam; Plà, Maria J.; Pernas, Sònia; Peñafiel, Judith; Yeste, Carlos; Gil-Gil, Miguel; Guedea Edo, Ferran; Ponce i Sebastià, Jordi; Laplana, Maria |
| 17-Jul-2018 | CDK4/6 inhibition in breast cancer: current practice and future directions | Pernas, Sònia; Tolaney, Sara M.; Winer, Eric P.; Goel, Shom |
| 29-Oct-2021 | Clinical Profile and Prognosis of a Real-World Cohort of Patients With Moderate or Severe Cancer Therapy-Induced Cardiac Dysfunction | Esteban-Fernández, Alberto; Carvajal Estupiñan, Juan Fernando; Gavira, Juan José; Pernas, Sònia; Moliner, Pedro; Garay, Alberto; Sánchez-González, Álvaro; Fernández-Rozas, Inmaculada; González-Costello, José |
| 1-Jan-2021 | COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry | Garrigós, Laia; Saura, Cristina; Martinez-Vila, Clara; Zambelli, Alberto; Bower, Mark; Pistilli, Barbara; Lambertini, Matteo; Ottaviani, Diego; Diamantis, Nikolaos; Lumsden, Ailsa; Pernas, Sònia; Generali, Daniele; Seguí, Elia; Viñas, Gemma; Felip, Eudald; Sánchez, Ana; Rizzo, Gianpiero; Santoro, Armando; Cortellini, Alessio; Perone, Ylenia; Chester, John; Iglesias, María; Betti, Marta; Vincenzi, Bruno; Libertini, Michela; Mazzoni, Francesca; Zoratto, Federica; Berardi, Rossana; Guida, Annalisa; Wuerstlein, Rachel; Loizidou, Angela; Sharkey, Rachel; Aguilar Company, Juan; Matas, Marta; Saggia, Chiara; Chiudinelli, Lorenzo; Colomba-Blameble, Emeline; Galazi, Myria; Mukherjee, Uma; Van Hemelrijck, Mieke; Marin, Mar; Strina, Carla; Prat Aparicio, Aleix; Pla, Helena; Ciruelos, Eva; Bertuzzi, Alexia; Mastro, Lucia del; Porzio, Giampiero; Newsom-Davis, Thomas; Ruiz, Isabel; Delany, Maria Belen; Krengli, Marco; Fotia, Vittoria; Viansone, Alessandro; Chopra, Neha; Romeo, Margarita; Salazar Soler, Ramón; Pérez Catalán, Ignacio; D’Avanzo, Francesca; Franchi, Michela; Milani, Manuela; Pommeret, Fanny; Tucci, Marco; Pedrazzoli, Paolo; Harbeck, Nadia; Ferrante, Daniela; Pinato, David J.; Gennari, Alessandra |
| 1-Jan-2022 | Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer | Pernas, Sònia; Guerriero, Jennifer L.; Naumenko, Sergey; Goel, Shom; Regan, Meredith M.; Hu, Jiani; Harrison, Beth T.; Lynce, Filipa; Lin, Nancy U.; Partridge, Ann; Morikawa, Aki; Hutchinson, John; Mittendorf, Elizabeth A.; Sokolov, Artem; Overmoyer, Beth |
| 1-Mar-2019 | HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance | Pernas, Sònia; Tolaney, Sara M. |
| 28-Apr-2023 | HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer | Olivera Salguero, Rubén; Seguí, Elia; Cejalvo, Juan Miguel; Oliveira, Mafalda; Tolosa, Pablo; Vidal, Maria; Malumbres, Marcos; Gavilá, Joaquín; Saura, Cristina; Pernas, Sònia; López, Rafael; Margelí Vila, Mireia; Balmaña, Judith; Muñoz, Montserrat; Blancas, Isabel; Boni, Valentina; Ciruelos, Eva; Galve Calvo, Elena; Perelló, Antonia; Sánchez Bayona, Rodrigo; Cruz, Susana de la; Hoya, Miguel de la; Galván, Patricia; Sanfeliu, Esther; González Farré, Blanca; Sirenko, Valeria; Blanch Torras, Aura; Canes, Jordi; Masanas, Helena; Olmos, Rosa; Forns, Margarita; Prat Aparicio, Aleix; Casas, Ana; Pascual, Tomás |
| 19-Mar-2021 | Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer | Griguolo, Gaia; Serna, G.; Pascual, Tomás; Fasani, R.; Guardia, X.; Chic, Núria; Paré, Laia; Pernas, Sònia; Muñoz Mateu, Montserrat; Oliveira, Mafalda; Vidal, M.; Llombart Cussac, Antonio; Cortés, Javier; Galván, Patricia; Bermejo de las Heras, Begoña; Martínez, N.; López, R.; Morales, Serafín; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, E.; Villagrasa, Patricia; Prat Aparicio, Aleix; Nuciforo, Paolo |
| 9-Feb-2021 | Lights and Shadows in Immuno-Oncology Drug Development | Bergamino Sirvén, Milana; Pernas, Sònia; Cheang, Maggie C. U. |
| 9-Jul-2021 | Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study | Gil Gil, Miguel; Bellet Ezquerra, Meritxell; Bergamino Sirvén, Milana; Morales, Serafín; Barnadas, Agustí; Manso, Luis; Saura, Cristina; Fernández Ortega, Adela; Garcia Martinez, Elena; Martinez Jañez, Noelia; Melé, Mireia; Villagrasa, Patricia; Celiz, Pamela; Perez Martin, X.; Ciruelos, Eva; Pernas, Sònia |
| 13-Jul-2015 | Lymphangioleiomyomatosis biomarkers linked to lung metastatic potential and cell stemness | Ruiz de Garibay, Gorka; Herranz, Carmen; Llorente, Alicia; Boni, Jacopo; Serra-Musach, Jordi; Mateo González, Francesca; Aguilar, Helena; Gómez Baldó, Laia; Petit, Anna; Vidal-Bel, August; Climent, Fina; Hernández-Losa, Javier; Cordero, Alex; González Suárez, Eva; Sanchez-Mut, Jose Vicente; Esteller, Manel; Llatjós, Roger; Varela Rodríguez, Mar; López, José Ignacio; García, Nadia; Extremera, Ana I.; Gumà i Garcia, Anna Maria; Ortega, Raúl; Pla Farnós, María Jesús; Fernández, Adela; Pernas, Sònia; Falo, Catalina; Morilla, Idoia; Campos, Miriam; Gil, Miguel; Román, Antonio; Molina Molina, María; Ussetti, María Piedad; Laporta, Rosalía; Valenzuela, Claudio; Ancochea Bermúdez, Julio; Xaubet Mir, Antonio; Casanova, Álvaro; Pujana Genestar, M. Ángel |
| 28-Feb-2022 | Metformin and Breast Cancer: Where Are We Now? | Cejuela, Mónica; Martin Castillo, Begoña; Menendez, Javier A.; Pernas, Sònia |
| 15-Jan-2019 | Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients | Cuyàs, Elisabet; Fernández Arroyo, Salvador; Buxó, Maria; Pernas, Sònia; Dorca, Joan; Álvarez, Isabel; Martínez, Susana; Pérez García, José Manuel; Batista López, Norberto; Rodríguez Sánchez, César A.; Amillano, Kepa; Domínguez, Severina; Luque, Maria; Morilla, Idoia; Stradella, Agostina; Viñas, Gemma; Cortés, Javier; Verdura, Sara; Brunet, Joan; López Bonet, Eugeni; Garcia, Margarita; Saidani, Samiha; Joven, Jorge; Martin Castillo, Begoña; Menendez, Javier A. |
| 1-Dec-2019 | Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer | López Bonet, Eugeni; Buxó, Maria; Cuyàs, Elisabet; Pernas, Sònia; Dorca, Joan; Álvarez López, Isabel; Martinez, Susana; Pérez García, José Manuel; Batista López, Norberto; Rodríguez Sánchez, César A.; Amillano, Kepa; Domínguez, Severina; Luque, Maria; Morilla, Idoia; Stradella, Agostina; Viñas, Gemma; Cortés, Javier; Oliveras, Glòria; Melendez, Cristina; Castillo, Laura; Verdura, Sara; Brunet, Joan; Joven, Jorge; Garcia, Margarita; Saidani, Samiha; Martin Castillo, Begoña; Menendez, Javier A. |
| 25-Sep-2019 | PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution | Pernas, Sònia; Petit, Anna; Climent, Fina; Paré, Laia; Perez Martin, J.; Ventura, Luz; Bergamino Sirvén, Milana; Galván, Patricia; Falo, Catalina; Morilla, Idoia; Fernandez Ortega, Adela; Stradella, Stradella; Rey, Montse; Garcia Tejedor, Amparo; Gil Gil, Miguel; Prat Aparicio, Aleix |
| 20-Jan-2020 | Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade | Brasó Maristany, Fara; Griguolo, Gaia; Pascual, Tomás; Paré, Laia; Nuciforo, Paolo; Llombart Cussac, Antonio; Bermejo de las Heras, Begoña; Oliveira, Mafalda; Morales, Serafín; Martínez, Noelia; Vidal Losada, Maria Jesús; Adamo, Barbara; Martínez, Olga; Pernas, Sònia; López, Rafael; Muñoz Mateu, Montserrat; Chic, Núria; Galván, Patricia; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, Eduardo; Gregorio, Sara; Gomis, Roger R.; Villagrasa, Patricia; Cortés, Javier; Ciruelos, Eva; Prat Aparicio, Aleix |
| 30-Mar-2021 | RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer | Sanz Moreno, Adrián; Palomeras, Sonia; Pedersen, Kim; Morancho, Beatriz; Pascual, Tomás; Galván, Patricia; Benítez, Sandra; Gómez Miragaya, Jorge; Ciscar, Marina; Jimenez, Maria; Pernas, Sònia; Petit, Anna; Soler, María Teresa; Viñas, Gemma; Alsaleem, Mansour; Rakha, Emad A.; Green, Andrew R.; Santamaria, Patricia G.; Mulder, Celine; Lemeer, Simone; Arribas, Joaquín V. (Vicente); Prat Aparicio, Aleix; Puig, Teresa; González Suárez, Eva |
| 21-Nov-2019 | Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center | Sirven, Milana Bergamino; Fernández Ortega, Adela; Stradella, Agostina; Morilla, Idoia; Falo, Catalina; Vázquez, Silvia; Castany, Roser; Villanueva, Rafael; Recalde, Sabela; Navarro Pérez, Valentí; Gil Gil, Miguel; Pernas, Sònia |
| May-2017 | Resistance to taxanes in triple negative breast cancer associates with the dynamics of a CD49f+ tumor initiating population | Gómez Miragaya, Jorge; Palafox Sánchez, Marta; Paré, Laia; Yoldi, Guillermo; Ferrer, Irene; Vila, Sergi; Galván, Patricia; Pellegrini, Pasquale; Pérez-Montoyo, Hector; Igea, Ana; Muñoz Moruno, Purificación; Esteller, Manel; Nebreda, Àngel R.; Urruticoechea Ribate, Ander; Morilla, Idoia; Pernas, Sònia; Climent, Fina; Soler, María Teresa; Petit, Anna; Serra Elizalde, Violeta; Prat Aparicio, Aleix; González Suárez, Eva |